The medical device company received the grant from the National Institute of Dental and Craniofacial Research, according to a June 7 news release. The grant will help RevBio complete pre-clinical research to advance the product into the clinical stage of development.
RevBio previously received funding from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center and Irvine, Calif.-based DSO Pacific Dental Services.
